Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

NCT03668600 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

230

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision to stop the program

Conditions

Depressive Disorder, Major

Interventions

DRUG: Rapastinel

Sponsor

Naurex, Inc, an affiliate of Allergan plc